Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
UBS
QuintilesIMS
Argus Health
Accenture
Deloitte
Queensland Health
Johnson and Johnson
Cipla

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,688,769

« Back to Dashboard

Title: Treatment method
Abstract:A method for inhibiting ovarian steroidogenesis in women comprising administering to women an ovarian steroidogenesis inhibitorilly effective amound of D Ser (tbu).sup.6 des Gly NH.sub.2 .sup.10 LH-RH ethylamide.
Inventor(s): Labrie; Fernand (Quebec, CA), Raynaud; Jean-Pierre (Paris, FR)
Assignee: Uclaf; Roussel (FR)
Filing Date:Nov 30, 1994
Application Number:08/347,054
Claims:1. A method for inhibiting ovarian steroidogenesis in women comprising administering to normal women with regular menstrual cycles an ovarian steroidogenesis inhibitorally effective amount of at least one peptide of the formula

wherein (a) Z is Gly-NH.sub.2, Y is Leu and X is Gly, (b) Z is Gly-NH.sub.2, Y is Leu, X is DN Leu, DN Val, D Abu (.alpha.-aminobutyric acid), D Phe, D Ser, D Thr, D Met, D Pgl, D Lys, Leu, Ile, Nle, Val, N-Val, Met, Phe, D Leu, D Arg, D ser (tbu), D Thr (tbu), D Cys (tbu), D Asp (O tbu), D Glu (Otbu), D Orn (boc), D Lys (boc), D Trp, Trp, 2-methyl Ala, D Tyr, D Met, .epsilon.-lauryl D Lys, .epsilon.-dextran-D Lys, (c) Z is NH-cyclopropyl- or NH-Alk wherein Alk is alkyl of 1 to 3 carbon atoms, Y is Leu and X is D Ser (tbu), D Thr (tbu), D Asp (Otbu), D Glu (Otbu), D Orn (boc), D Lys (boc), (d) Z is --NH--CH.sub.3, --NH--CH.sub.2 --CH.sub.3,--NH--CH.sub.2 --CH.sub.2 --CH.sub.3, --NH--C.H.sub.2 --CH.sub.2 --OH, ##STR2## Y is Leu and X is Gly, (e) Z is --NH--CH.sub.2 --CH.sub.3, Y is Leu and X is D Trp, D Leu, D Ala, D Ser (tbu), D Tyr, D Lys, Ala, (f) Z is Gly-NH.sub.2 or --NH--CH.sub.2 --CH.sub.3, Y is N.alpha.Met Leu and X is Gly (g) Z is --NH-cyclopropyl, Y is Leu and X is D Leu or (h) Z is Gly-NH.sub.2, --NH-cyclopropyl or --NHAlk' where Alk' is alkyl of 1 to 3 carbon atoms, Y is Ser (but), Cys (but), Asp (Obut), Glu (Obut), --Orn (boc), Lys (boc) and X is Gly.

2. A method for inhibiting ovarian steroidogenesis in women comprising administering to women with regular menstrual cycles an ovarian steroidogenesis inhibitorally effective amount of D Ser (tbu).sup.6 des Gly NH.sub.2 .sup.10 LH-RH ethylamide.

3. The method of claim 2 wherein the compound is administered nasally as a solution containing 500 .mu.g of the compound per dose.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
McKesson
Teva
Daiichi Sankyo
Citi
Cantor Fitzgerald
Johnson and Johnson
Queensland Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.